However, the main focus of that study was not to establish an in vivo model for glioma-related epilepsy, but to investigate a role for glioma-induced alterations in KCC2 in the peritumoral region in tumor-associated epilepsy and therefore, no detailed characterization of seizures was given [33]. Here, SLC12A5 is linked to central nervous system cancer.